Eligibility Pre-Screening

Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 80%

1.Have you been diagnosed with locally advanced rectal cancer (LARC)?

Press Y/N or 1/2